Delos Santos, Marcelin A.
HRN: 04-33-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2022
METRONIDAZOLE 500MG (TAB)
07/24/2022
07/31/2022
PO
500mg
Q8
Post CS; Thickly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes